[SCHEDULE 13G] GlycoMimetics, Inc. SEC Filing

Rhea-AI Filing Summary

Crescent Biopharma, Inc. received a Schedule 13G disclosing that 1Globe Capital LLC and its chairman, Jiaqiang Li, report shared beneficial ownership of 896,712 ordinary shares, representing 6.45% of the outstanding class based on 13,892,562 shares. The filing states the shares are held with shared voting and dispositive power and that the holdings were not acquired to influence control of the issuer. Reporting addresses include One International Place, Boston, MA, while the issuer’s principal office is listed in Waltham, MA. The Schedule is dated for the event on 08/13/2025 and signed on 08/20/2025.

Insights

Securities Analyst

TL;DR: A >5% passive stake (6.45%) is disclosed by 1Globe Capital LLC and chairman Jiaqiang Li, a notable minority position that must be monitored.

The Schedule 13G shows 896,712 shares held with shared voting and dispositive power, equaling 6.45% of the class based on the issuer's reported 13,892,562 shares outstanding. The filing is under rules for passive investors and includes a certification that the holdings are not intended to alter control. For investors, this is material disclosure of concentration but is consistent with a passive stake rather than an active takeover attempt.

Corporate Governance Expert

TL;DR: Disclosure identifies an identifiable individual (chairman of reporting entity) with shared authority over a meaningful minority position; governance implications are limited by the passive filing.

The document names both the reporting entity (1Globe Capital LLC) and an individual (Jiaqiang Li) who may be deemed the ultimate beneficial owner while disclaiming direct beneficial ownership beyond pecuniary interest. The filing specifies shared voting/dispositive power and includes the required certification that the position is not held to influence control. This satisfies disclosure obligations and signals transparency on potential influence channels without asserting active control intentions.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Crescent Biopharma, Inc.

(Name of Issuer)

Ordinary Shares, par value $0.001 per share

(Title of Class of Securities)

38000Q201

(CUSIP Number)

08/13/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 38000Q201

1

Names of Reporting Persons

1Globe Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 896,712.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 896,712.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

896,712.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.45 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Jiaqiang Li serves as the Chairman of 1Globe Capital LLC and directly or indirectly exercises voting and dispositive power over the Issuer's shares held by 1Globe Capital LLC and as such, Mr. Li may be deemed the ultimate beneficial owner of such shares. Each Reporting Person disclaims beneficial ownership of such securities that are not directly owned by such Reporting Person, except to the extent of its or his pecuniary interest therein.

SCHEDULE 13G

CUSIP No. 38000Q201

1

Names of Reporting Persons

Jiaqiang Li

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CHINA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 896,712.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 896,712.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

896,712.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.45 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Jiaqiang Li serves as the Chairman of 1Globe Capital LLC and directly or indirectly exercises voting and dispositive power over the Issuer's shares held by 1Globe Capital LLC and as such, Mr. Li may be deemed the ultimate beneficial owner of such shares. Each Reporting Person disclaims beneficial ownership of such securities that are not directly owned by such Reporting Person, except to the extent of its or his pecuniary interest therein.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Crescent Biopharma, Inc.
(b)	Address of issuer's principal executive offices: 300 Fifth Avenue, Waltham, MA, 02451
Item 2.
(a)	Name of person filing: 1Globe Capital LLC; Jiaqiang Li
(b)	Address or principal business office or, if none, residence: One International Place, 44th Fl, Boston, MA 02110
(c)	Citizenship: 1Globe Capital LLC is a Delaware Limited Liability Company; Jiaqiang Li is a citizen of the People's Republic of China
(d)	Title of class of securities: Ordinary Shares, par value $0.001 per share
(e)	CUSIP No.: 38000Q201
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information required by this Item 4(a) is set forth in Row (9) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
(b)	Percent of class: 6.45% for each Reporting Person hereto (based on the 13,892,562 shares outstanding as of July 25, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 14, 2025).
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The information required by this Item 4(c)(i) is set forth in Row (5) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
	(ii) Shared power to vote or to direct the vote: The information required by this Item 4(c)(ii) is set forth in Row (6) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
	(iii) Sole power to dispose or to direct the disposition of: The information required by this Item 4(c)(iii) is set forth in Row (7) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
	(iv) Shared power to dispose or to direct the disposition of: The information required by this Item 4(c)(iv) is set forth in Row (8) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

1Globe Capital LLC

Signature:	/s/ Jiaqiang Li
Name/Title:	Chairman
Date:	08/20/2025

Jiaqiang Li

Signature:	/s/ Jiaqiang Li
Name/Title:	Reporting person
Date:	08/20/2025